IQVIA Cell and Gene Therapy Center

Driving stem cell development from candidate identification through market authorization

Fact Sheet

IQVIA Stem Cell Center FS

The focus in Regenerative Medicine (RMx) is changing from bench medicine to clinical-commercial success. RMx faces many headwinds: complex preclinical/nonclinical models, constrained clinical manufacturing capacity, limited clinical sites with RMx experience, shifting regulatory landscape and an unclear pathway for pricing and market access.